The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, double-blind, placebo-controlled trial (ALLIANCE A221602).
 
Rudolph M. Navari
Research Funding - HERON (Inst)
Travel, Accommodations, Expenses - HERON
 
Jennifer Le-Rademacher
No Relationships to Disclose
 
Fabrice Smieliauskas
No Relationships to Disclose
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic are involved in a potential equity/royalty relationship with AliveCor. (I); Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Thomas James Saphner
No Relationships to Disclose
 
Heshan Liu
No Relationships to Disclose
 
Beth Harlos
No Relationships to Disclose
 
Adedayo A. Onitilo
No Relationships to Disclose
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Novartis (Inst)
Research Funding - Pfizer (Inst)
 
Preet Paul Singh
No Relationships to Disclose
 
Pavan S. Reddy
No Relationships to Disclose
 
Flavio Kruter
No Relationships to Disclose
 
George Raptis
No Relationships to Disclose
 
Charles L. Loprinzi
Consulting or Advisory Role - Denali Therapeutics; Disarm Therapeutics; Grunenthal; Hengrui Pharmaceutical; Metys Pharmaceuticals; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; Neuropathix; NKMax; OnQuality Pharmaceuticals; Osmol Therapeutics; PledPharma; Veloxis
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Cynosure/Hologic